Singlera Genomics
Business Services · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
505 Coast Blvd S Ste 309, La Jolla, Cali...Website
www.singlera.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Singlera Genomics
Singlera Genomics Inc is a company that operates in the Biotechnology industry. It employs 21-50 people and has $1M-$5M of revenue.Explore more
Singlera Genomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Singlera Genomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Singlera Genomics recently announced quarterly report
Click to see if Singlera Genomics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Singlera Genomics has new funding data
Product Launch: Get notified when Singlera Genomics launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Singlera Genomics, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Singlera Genomics is spiking on competitors!
Website visits: Recent activity has been detected on your website
Check if Singlera Genomics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Singlera Genomics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Singlera Genomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Singlera Genomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Singlera Genomics.
Singlera Genomics financials insights
Gather financial insights about Singlera Genomics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$20M
2020
Debt
$150K
Series B
$150M
Singlera Genomics Tech Stack
A closer look at the technologies used by Singlera Genomics
Singlera Genomics News & Media
Singlera Genomics announces research collaboration with the University of Pittsburgh to advance pancreatic cancer early detection
LA JOLLA, Calif., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, with their partner Breakthrough Genomics, a leader in the clinical analysis of genomic data and early cancer diagnostics, today announced a research collaboration with the University of Pittsburgh (Pitt) to advance the preclinical evaluation of Singlera and Breakthrough’s BT-Reveal™ Early Pancreatic Cancer Test.Singlera Genomics and Partners publish results from GUIDE prospective cohort study demonstrating blood-based early detection of gastrointestinal cancers using DNA methylation-based GutSeer assay
SAN DIEGO and SHANGHAI, China, June 17, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics, a biotechnology company focused on non-invasive early cancer detection, and Fudan University’s Zhongshan Hospital, a premier highly ranked public hospital in China, today announced the publication of a peer-reviewed manuscript in the journal Molecular Cancer demonstrating the results of the large-scale multi-center GUIDE prospective cohort study, showing that Singlera’s GutSeer® assay can non-invasively detect fiSinglera Genomics Presented Non-Invasive Testicular Toxicity Detection with Astellas at 2025 SOT Meeting
SAN DIEGO, March 24, 2025 (GLOBE NEWSWIRE) -- Singlera Genomics presented results showing a refined approach to detect drug-induced testicular toxicity using Singlera’s cell-free DNA methylation technology with Astellas during the SOT 2025 Annual Meeting.Singlera Genomics presents results of PDACatch preclinical study at HM Hospitals Annual Early Detection Meeting
SAN DIEGO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Singlera Genomics, a company focused on the application of novel DNA methylation technologies to genetic diagnosis, presented the results of its initial preclinical study of the PDACatch test, an assay to detect pancreatic cancer in individuals at high risk for the disease, at the HM Hospitals annual Hyper-early Diagnosis in Oncology and its Clinical Management meeting.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Singlera Genomics
Sign Up For FreeTo access detailed company insights
Singlera Genomics Inc is a company that operates in the Biotechnology industry. It employs 21-50 people and has $1M-$5M of revenue.... Read More
